# Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

> **NCT02485548** · PHASE3 · UNKNOWN · sponsor: **Jiangsu Cancer Institute & Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Cancer

## Interventions

- **DRUG:** Raltitrexed
- **DRUG:** 5-fluorouracil
- **DRUG:** Cisplatin
- **RADIATION:** IMRT

## Key facts

- **NCT ID:** NCT02485548
- **Lead sponsor:** Jiangsu Cancer Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2015-06-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02485548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02485548, "Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02485548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*